Japanese multinational pharmaceutical company Takeda is revolutionizing healthcare in Serbia by introducing digitalization projects and new technologies that have improved access to healthcare for millions of people in the country.

Takeda Serbia Director and Country Head Milena Argirovic shared with GMI POST how Asia’s largest pharmaceutical has strengthened Serbia’s healthcare system over the past 10 years and how it wants to provide full value to the country.
“Our priority is to introduce innovations that support biotechnology and data utilization in healthcare,” said Argirovic, who reaffirmed Takeda’s commitment to work closely with the government and various sectors to deliver a healthier future.
Takeda is grateful for the cooperation of Serbia’s private and public sectors, including the Office for IT and eGovernment and the Ministry of Health, as well as Heliant company, in the creation and the implementation of telemedicine and telehealth services, the first ever of its kind in Serbia. Through a video call, any Serb, regardless of location, can undergo medical examinations or have a consultation.
On Takeda’s future plans in Serbia, Argirovic is most excited about further driving health and biotech innovation across various sectors to expand access to quality healthcare.
Among its efforts in Serbia are projects with the Ministry of Science, Institute for Molecular Genetics and Genetic Engineering, Institute for Artificial Intelligence, the Centre for the Fourth Industrial Revolution, and the BIO4 Campus, a new bio-economic camp in Belgrade that focuses in biomedicine, biotechnology, bioinformatics, and biodiversity.